NCT02537743 Prospective Patient Reported Outcomes (PRO) Registry in Patients With Advanced Renal Cell Carcinoma Status COMPLETED Phase N/A
NCT02533258 Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine Practice Status COMPLETED Phase N/A
NCT02527304 Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery Status COMPLETED Phase NA
NCT02526017 Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers Status COMPLETED Phase PHASE1
NCT02498665 A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT02496208 Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02495103 Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT02473536 Neo-adjuvant SABR for IVC Tumor Thrombus in Newly Diagnosed RCC Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02446860 A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR) Status TERMINATED Phase PHASE2
NCT02446795 Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial Status UNKNOWN Phase PHASE1/PHASE2
NCT02440334 Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation Status COMPLETED Phase PHASE2
NCT02432963 Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02420821 A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC) Status COMPLETED Phase PHASE3
NCT02410174 To Evaluate Stereotactic Body Radiotherapy for Treatment of Primary Renal Cell Carcinoma Tumors Status TERMINATED Phase PHASE1
NCT02399124 Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase NA
NCT02390843 Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors Status COMPLETED Phase PHASE1
NCT02386826 INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT02370290 Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer Status COMPLETED Phase N/A
NCT02338570 Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE) Status TERMINATED Phase PHASE4
NCT02326558 Comparison of Microwave Ablation-Assisted Enucleation and Conventional Laparoscopic Partial Nephrectomy in the Treatment of T1a Renal Cell Carcinoma Status COMPLETED Phase NA